Literature DB >> 12077699

Considerations in metatarsalgia and midfoot pain: an MR imaging perspective.

Joseph S Yu1, Jonathan R Tanner.   

Abstract

There are many conditions that have the potential to produce the symptom of pain in the metatarsal and midfoot regions. Pathologic processes that cause pain include post-traumatic disorders, circulatory disorders, arthritides, neuroarthropathy, and conditions that result in a biomechanical imbalance in the foot. Magnetic resonance (MR) imaging is a powerful imaging tool since it provides a noninvasive method for diagnosis of different foot disorders. In this article, we will discuss the MR manifestation of a number of pathologic entities that elicit foot pain as a primary symptom.

Entities:  

Mesh:

Year:  2002        PMID: 12077699     DOI: 10.1055/s-2002-32356

Source DB:  PubMed          Journal:  Semin Musculoskelet Radiol        ISSN: 1089-7860            Impact factor:   1.777


  4 in total

1.  Pseudotumoral appearance of a ruptured epidermal cyst in the foot.

Authors:  Srinivasan Harish; Edgar Jan; Michelle Ghert; Salem Alowami; Karen Finlay
Journal:  Skeletal Radiol       Date:  2006-06-08       Impact factor: 2.199

2.  First metatarsophalangeal joint- MRI findings in asymptomatic volunteers.

Authors:  Tobias Johannes Dietrich; Flora Luciana Figueira da Silva; Marcelo Rodrigues de Abreu; Georg Klammer; Christian W A Pfirrmann
Journal:  Eur Radiol       Date:  2014-11-21       Impact factor: 5.315

3.  MRI of lesser metatarsophalangeal joint plantar plate tears and associated adjacent interspace lesions.

Authors:  Hilary Umans; Ramya Srinivasan; Elisabeth Elsinger; Gregory E Wilde
Journal:  Skeletal Radiol       Date:  2014-06-01       Impact factor: 2.199

4.  Correlations between subjective treatment responses and plantar pressure parameters of metatarsal pad treatment in metatarsalgia patients: a prospective study.

Authors:  Jiunn-Horng Kang; Min-Der Chen; Shih-Ching Chen; Wei-Li Hsi
Journal:  BMC Musculoskelet Disord       Date:  2006-12-05       Impact factor: 2.362

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.